Fertility Services Market Overview, 2025-30

The global fertility services market has grown from the world’s first IVF birth in the United Kingdom in 1978 to a highly structured ecosystem spanning advanced clinics, pharmaceutical suppliers, and technology innovators. Today, networks like IVI-RMA Global in Spain, Shady Grove Fertility in the United States, and Virtus Health in Australia anchor the market with international footprints, while regulatory bodies such as the Human Fertilisation and Embryology Authority in the UK and the European Society of Human Reproduction and Embryology set benchmarks for practice.

Differences remain stark, with Denmark and Israel providing extensive public funding for multiple IVF cycles while patients in many parts of Africa and Asia still rely on out-of-pocket spending. Fertility tourism has become a global phenomenon, with Spain, Greece, Thailand, and Mexico receiving patients from countries with restrictive donor or surrogacy laws, creating flows that reshape patient experiences across borders. Oncofertility programs have expanded in cancer centers such as MD Anderson in the United States and Monash Health in Australia, offering gamete preservation before chemotherapy.

Egg freezing, once experimental, is now mainstream in Asia and Europe, with countries like Singapore recently legalizing social freezing for single women, reflecting how cultural norms are shifting. Technology adoption is rapid, with AI-based embryo selection from companies like Alife Health in the US and Genea’s time-lapse incubators in Australia improving outcomes, while genetic testing firms like Natera and CooperGenomics integrate precision medicine into routine ART.

The workforce challenge remains, with a shortage of trained embryologists in developing economies, pushing clinics to partner with universities to expand training pipelines. Declining birth rates in countries from Japan to Italy combined with rising male infertility linked to pollution and lifestyle globally underline the demographic urgency driving demand, positioning fertility services as both a personal healthcare need and a societal priority.

According to the research report, “Global Fertility Services Market Overview, 2030”, the Global Fertility Services market is expected to cross USD 60.29 Billion market size by 2030, with 9.02% CAGR by 2025-30. Leading providers like Inception Fertility in the US and IVI-RMA Global in Spain are pursuing acquisitions to create multinational footprints, while Indian groups such as Apollo Fertility and Cloudnine are scaling domestically to serve rising demand. Pharmaceutical giants including Merck, Ferring, and IBSA dominate the supply of hormonal drugs worldwide, while consumables from German manufacturers like Eppendorf support embryology labs.

Employer-driven benefits are expanding, with technology companies such as Google, Apple, and Meta covering IVF and egg freezing as part of recruitment and retention strategies, a trend spreading beyond North America into Europe and Asia. Legal cases have brought fertility into public debate, including frozen embryo custody disputes in the United States and cross-border surrogacy controversies in India and Thailand that have reshaped national laws. Benchmarking of outcomes is becoming standard, with the Society for Assisted Reproductive Technology in the US and ESHRE in Europe publishing clinic success rates, while some Asian countries are building national registries.

Financing models are diversifying, from IVF loans in Brazil to insurance-backed schemes in Israel and state subsidies in Japan, reflecting different approaches to accessibility. Data privacy is emerging as a global concern as genetic testing integrates into ART, with regions such as Europe enforcing GDPR compliance and China strengthening data security laws.

Public awareness campaigns are expanding in countries like South Korea where ultra-low birth rates have triggered government-funded programs to encourage fertility treatment. At the same time, debates about the ethics of CRISPR embryo editing following the 2018 experiment in China, and research into artificial wombs in Japan and the Netherlands, show how future technologies challenge current frameworks.

Market Drivers

• Rising global infertility prevalence: Across the world, infertility is no longer confined to isolated regions but has become a widespread concern, affecting men and women alike. Factors such as urban lifestyles, delayed marriages, stress, environmental toxins, and medical conditions like PCOS and endometriosis are contributing to a universal rise in infertility rates. This global health issue has created an unprecedented demand for assisted reproductive technologies, making fertility services a central part of modern healthcare systems.
• Greater acceptance of diverse family structures: Globally, fertility services are increasingly embraced by a wider audience, including same-sex couples, single parents by choice, and people preserving fertility for social or medical reasons. Changing cultural attitudes and supportive legal frameworks in many countries have expanded the patient base far beyond traditional heterosexual couples. This acceptance has broadened the scope of fertility care, fueling global demand and reshaping the way societies perceive family building.

Market Challenges

• Uneven distribution of fertility services: While advanced fertility centers are concentrated in North America, Europe, and parts of Asia-Pacific, large populations in Africa, Latin America, and South Asia still lack access to affordable and modern fertility care. This uneven distribution of infrastructure creates global disparities, with some patients forced to travel abroad for treatment while others remain underserved, highlighting access inequality as a major worldwide challenge.
• Ethical debates and regulatory variations: Globally, fertility services face ongoing debates over embryo freezing, donor anonymity, genetic testing, and surrogacy. Countries adopt vastly different laws, creating confusion for patients who often pursue cross-border fertility tourism. These variations not only complicate the patient journey but also raise ethical questions about commercialization of reproduction, making regulatory inconsistency a major obstacle for the global fertility services market.

Market Trends

• Integration of digital health and AI: Worldwide, fertility clinics are adopting artificial intelligence for embryo selection, time-lapse incubators for monitoring embryo development, and telemedicine for consultations. These digital tools are improving IVF success rates, enhancing patient experience, and making fertility care more accessible across borders. The global embrace of digital health represents a major technological shift in fertility services.
• Expanding fertility preservation practices: Egg, sperm, and embryo banking are becoming global norms, driven by delayed parenthood and medical needs like cancer treatment. Employers in the US, Europe, and Asia now offer egg freezing as a workplace benefit, while rising awareness in emerging economies is encouraging younger generations to preserve fertility earlier. This trend reflects how proactive reproductive planning is becoming part of global family-building strategies.Surrogacy is the fastest growing procedure in the global fertility services market because it provides a solution for individuals and couples who cannot carry a pregnancy themselves, while also serving diverse family structures.

The Global Fertility Services Market has seen surrogacy grow rapidly because it meets a unique medical and social need that no other assisted reproduction method can address. For women with medical conditions such as absence of a uterus, severe uterine scarring, recurrent pregnancy loss, or serious health risks that make pregnancy unsafe, surrogacy becomes the only pathway to having a genetically related child. At the same time, surrogacy has opened parenthood possibilities for same-sex male couples and single men who wish to build families with their own genetic link, which has expanded its relevance beyond strictly medical necessity.

The practice has gained visibility as more high-profile cases, including celebrities and public figures, have openly used surrogacy, which has reduced stigma and increased awareness. Advances in IVF and embryo transfer techniques have improved success rates for surrogacy, making it a more reliable choice compared to earlier decades. Globalization has also shaped surrogacy, with fertility tourism emerging in countries such as the United States, Georgia, Ukraine, India (historically before restrictions), and Thailand, where surrogacy laws and medical infrastructure allowed international patients to pursue treatment.

Legal variations across countries have created cross-border surrogacy arrangements, which, despite ethical debates, continue to fuel demand from regions where local laws are restrictive. The cultural emphasis on family and children in many societies ensures that couples are willing to invest emotionally and financially in surrogacy despite its complexity. Furthermore, the growing openness to non-traditional families has broadened its acceptance, particularly in progressive urban centers worldwide. Even with ongoing ethical and regulatory debates, the demand for surrogacy is only rising as more people delay parenthood, face infertility, or seek alternative paths to family building.

Fresh donor services are the fastest growing in the global fertility services market because they provide higher success rates and greater flexibility for patients seeking donor eggs or embryos.

The Global Fertility Services Market shows rapid growth in fresh donor services due to the practical advantages they offer in achieving pregnancies for couples and individuals with poor egg quality, advanced maternal age, or genetic concerns. Fresh donor eggs typically result in better fertilization and embryo development outcomes compared to frozen donor eggs, since they are retrieved and fertilized immediately without undergoing cryopreservation and thawing, which can affect survival rates. Many fertility specialists still recommend fresh donor cycles when success is the priority, particularly for older women or those with repeated IVF failures.

Beyond medical reasons, fresh donor arrangements also allow for more personalization, as intended parents often have the option to match with donors in terms of physical traits, background, and sometimes even to coordinate cycles to maximize the number of viable embryos. In countries where donor anonymity laws permit flexibility, this creates an appealing option for families who want closer alignment with their donor.

Fertility tourism has also played a role, as patients from regions with limited donor availability often travel to countries like Spain, India, Greece, or the United States to access a larger donor pool, many of which offer fresh donor programs. Cultural preferences also influence this demand, as many societies place importance on genetic continuity or selecting specific donor traits. Clinics have increasingly streamlined donor programs to make the process easier and faster, further driving uptake.

Male infertility is the fastest growing cause in the global fertility services market because lifestyle, environmental, and health-related factors are increasingly affecting male reproductive health worldwide.

The Global Fertility Services Market reflects the growing challenge of male infertility, as studies from multiple countries show that sperm counts and quality have been declining over the past few decades. Factors such as poor diet, obesity, smoking, alcohol consumption, and sedentary lifestyles are strongly linked to reduced sperm quality. Environmental pollution, including exposure to pesticides, plastics, and industrial chemicals, is also known to disrupt hormonal balance and affect male fertility. Stress and long working hours in urban settings contribute to hormonal imbalances that further reduce sperm function.

Medical conditions such as varicocele, infections, and untreated childhood illnesses can also impair sperm production, while rising rates of diabetes and other chronic diseases have worsened reproductive health among men. Another factor is delayed parenthood, as sperm quality also declines with age, though less dramatically than eggs. Awareness campaigns and better diagnostics, such as semen analysis, genetic screening, and hormonal profiling, have revealed the scale of male infertility, which was previously underdiagnosed due to cultural stigma that often placed responsibility for infertility on women.

The development of advanced procedures like intracytoplasmic sperm injection has made it possible for men with very low sperm counts or poor motility to father biological children, which has encouraged more couples to seek fertility services even in severe male factor cases. Male infertility is no longer a hidden issue, as public health organizations highlight its prevalence and encourage men to undergo testing alongside their partners.

Fertility clinics are the fastest growing end users in the global fertility services market because they provide specialized, comprehensive, and technologically advanced care that hospitals and surgical centers often cannot match.

The Global Fertility Services Market is increasingly driven by fertility clinics as the preferred setting for assisted reproduction because these centers are designed exclusively for diagnosing and treating infertility, giving them a clear advantage over general hospitals or surgical units. Fertility clinics concentrate all necessary services under one roof, including hormonal testing, imaging, embryology labs, IVF and ICSI procedures, genetic screening, counseling, and even egg and embryo banking. This integrated approach provides patients with a seamless journey from diagnosis to treatment, reducing delays and improving coordination between doctors, embryologists, and counselors.

Specialized clinics also invest heavily in cutting-edge technologies such as AI-based embryo selection, time-lapse imaging incubators, and advanced cryopreservation methods, which hospitals may not prioritize due to broader healthcare responsibilities. Their dedicated embryology labs maintain strict quality control standards, often exceeding general hospital capabilities, which directly impacts treatment success rates. Fertility clinics are also more flexible in offering donor programs, surrogacy coordination, and personalized treatment plans tailored to patient needs.

In many countries, fertility clinics operate as private entities, giving them the ability to innovate quickly, form international collaborations, and attract patients through transparent success reporting and marketing. The rise of fertility tourism has further supported specialized clinics, as international patients prefer dedicated centers with multilingual staff and streamlined processes.

The increasing acceptance of ART among diverse patient groups, including LGBTQ+ families and single parents, has also been facilitated more readily by fertility clinics that adapt policies faster than traditional hospital systems.Asia Pacific leads the global fertility services market because of the region’s unique blend of rising infertility rates, supportive medical infrastructure, cultural acceptance of assisted reproduction, and the growth of fertility tourism.

The Asia Pacific Fertility Services Market has emerged as a leader due to a convergence of demographic, cultural, and healthcare factors that few other regions can match. Across countries such as India, China, Japan, South Korea, Thailand, and Singapore, infertility is becoming more visible as delayed marriage, urban lifestyles, stress, and pollution affect both male and female reproductive health. This rise in infertility has created strong demand for treatments such as IVF, ICSI, and surrogacy, which are increasingly accessible in metropolitan cities through specialized fertility clinics.

Governments in some parts of the region have also recognized declining birth rates as a national issue, with countries like Japan and South Korea actively encouraging fertility treatment access as a way to offset population decline. Another defining factor is the affordability of procedures in emerging Asian nations compared to Western counterparts, which has encouraged cross-border fertility tourism.

India and Thailand, for instance, became well-known hubs for surrogacy and donor egg programs, attracting patients from the Middle East, Europe, and even North America before regulations tightened, while countries like Singapore and Malaysia have positioned themselves as premium fertility destinations with high-quality labs and internationally trained embryologists. In addition, the cultural emphasis on parenthood in many Asian societies has pushed couples to seek medical solutions rather than accept childlessness, which has normalized the use of ART.

Local pharmaceutical companies also contribute by supplying fertility drugs at lower costs, making treatment more accessible to middle-class populations. The integration of cutting-edge technologies, including time-lapse imaging of embryos and AI-based embryo selection, has been increasingly adopted in Asian fertility centers, demonstrating that the region is not just cost-effective but technologically competitive as well.

• In July 2025, IVI RMA Global acquired ART Fertility Clinics in the United Arab Emirates and Saudi Arabia, including three clinics with state-of-the-art facilities, from Gulf Capital. The acquisition strengthened IVI RMA's global footprint, including high-IVF-success, research-based protocols within its expansive network. This acquisition was subject to regulatory clearance and aligned with the company's global expansion priorities.
• In August 2025, Jamaican women were projected to average just 1.3 births per lifetime in 2025, according to a report from the United Nations Population Fund, marking one of the lowest fertility rates in the world. The average number of births fell well below the 2.1 births needed to keep a population stable, making Jamaica one of a very small number of countries to have lowest-low fertility rates.
• In June 2025, Guardian Life Insurance collaborated with Carrot to incorporate fertility health and family-building services into its hospital indemnity insurance product. The association made Guardian the first insurance company in this type of insurance to offer Carrot's fertility, prenatal, menopause, urology, and parenting support. Employees also had access to Carrot's Provider Finder, Carrot Academy, expertise, 24/7 care navigation, and more than 20 wellness benefits.
• In June 2025, the Fertility Partnership acquired VivaNeo GmbH, a major German provider operating more than 9 clinics and delivering about 14,000 cycles annually and generating around USD 58 million in revenue.
• In June 2025, Samartha Fertility and IVF, India’s leading fertility service provider, has announced the start of a mass IVF program. Under this program, Samartha is offering high quality IVF cycles at just USD 965 per cycle.

***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.